Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Earnings
Zeo ScientifiX's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q2 FY2026
$2.58M
EPS, Q2 FY2026
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Zeo ScientifiX's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2026ended Apr 30, 2026 | Jul 8, 2026before the open | $2.58M | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Zeo ScientifiX has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Zeo ScientifiX puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Zeo ScientifiX filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- News
- News
- ZEO ScientifiX Reports Strong Revenue Growth Of For Three Months and Six Months Ended April 30, 2026Results
- News
- News
- News
- News
- News
- News
- News
- News
- News
See a number that looks wrong?